d4T and lactic acidosis with neuromuscular weakness: FDA warning.
D000140:Acidosis, Lactic / Q000139:chemically induced* / Q000150:complications; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D018908:Muscle Weakness / Q000139:chemically induced*; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects*; D018119:Stavudine / Q000009:adverse effects*; D014481:United States; D014486:United States Food and Drug Administration
D018894:Reverse Transcriptase Inhibitors; D018119:Stavudine